Methocarbamol
Product Images NDC 51662-1435

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Methocarbamol (NDC 51662-1435). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Seerialized Labeling (Serialized Vial Labeling)

This is a pharmaceutical product called Methocarbamol Injection, used for Intravenous or Intramuscular use. It contains 1,000 mg /10 mL of the Methocarbamol active ingredient. It comes in a 10 mL Single Dose Vial and the package insert should be consulted for more information. It is distributed by HF Acquisition 8., LEC, located in Mukilteo, WA 98275, and the NDC number is 0517-182501. The manufacturer is American REGENT, INC. in Shirley, NY 11967.*

FDA Label Image

Structure (Structure)

FDA Label Image

Vial Label (Vial Label)

NDC 0517-1825-01 is a Methocarbamol injection containing 100mg/mL of Methocarbamol, USP and Polyethylene Glycol 300, NF 0.5 mL. It can be adjusted using hydrochloric acid and/or sodium hydroxide. Prior to injection, the solution needs to be mixed with intravenous infusion fluids and should not be refrigerated. Intravenous injection is recommended at a maximum of 3mL per minute with undiluted (200mg/mb) solution. Intramuscular injection is injected undiluted not more than 5 ml in each gluteal region. The dosage must be read from the package insert and it should be stored between 20° to 25°C (68° to 77°F) with excursions permitted between 15° to 30°C (59°F to 86°F).*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.